Wednesday, February 1, 2023
  • Login
The Science Serve
  • Home
  • Healthcare
  • Technology
  • Market
  • Contact Us
  • More
    • Privacy Policy
    • Disclaimer
    • Editorial Policy and Guidelines
    • Terms and Conditions
No Result
View All Result
The Science Serve
No Result
View All Result
Home Healthcare

Telomeres as a universal target in cancer therapy

Dr. Namrata Kumari by Dr. Namrata Kumari
June 22, 2020
in Healthcare
Reading Time: 3 mins read
0 0
A A
0
Telomeres as a universal target in cancer therapy
Share on FacebookShare on Twitter

Although clinically well tolerated and effective, existing cancer therapies are expensive and have long term side effects. The cost of some chemotherapy and immunotherapy infusions is three times the average monthly income of the American full-time salary workers. Therefore, improved cancer targets are being actively under intense investigation.

A new era of gene therapy is in progress for the possibility of a cure for cancer. Scientists are trying to introduce genes in tumours via genetically engineered vectors (adenovirus, retrovirus). The tumour cell surface antigen is being matched with a vector for successful acceptance and adsorption. However, identifying new targets to improve existing therapies could generate higher expectations. Few studies have indicated that the telomere is the Achilles’ heel of cancerous cells, as it serves to protect the chromosome from end-to-end fusion and/or degradation (chromosome instability). Much like a shoelace tip, the telomere is located at the end of a chromosome and consists of tandem DNA repeats, whereas telomerase is the associated enzyme which helps to replicate the telomeric end. The telomerase is turned off during normal cell division, resulting in senescence (cell division halted) or apoptosis (cell death). However, cancerous cell lines maintain the telomere length and therefore, can divide indefinitely. Interestingly, alterations in telomerase activity utilizing a modified telomerase enzyme or antisense oligonucleotides in various cancer cell lines have resulted in apoptosis or differentiation (potency for cell division halted). Therefore, telomerase inhibition could be a potential strategy for cancer treatment.

Photo by National Cancer Institute on Unsplash

Telomerase based treatments

Telomerase inhibitors

However, telomerase inhibition based treatments are being designed by various groups of scientists. The program mainly includes telomerase inhibitors, telomerase vaccines, and engineered oncolytic viruses. Briefly, telomerase inhibitor is an oligonucleotide, which is also called GRN163L. It directly binds with the active site of telomerase and therefore inhibits its activity. After that, the enzyme cannot replicate the telomeric end of cancer cells anymore, which halts the cell cycle. This therapy is already successful in lung, breast, prostate, and liver cancers at culture levels and work is in progress for animal studies.

Telomerase vaccines

Tumour-associated antigens to develop immunity against tumour exists in both human and animal models. Unfortunately, these antigens are very specific and vary for types of cancer and even immunity of an individual. Therefore, the target for vaccine preparation is uncertain today. However, studies claim that telomerase could be the universal target, as expressed in the majority of cancer cells. Earlier, clinical trials for vaccine formulation on human telomerase reverse transcriptase (the catalytic subunit of telomerase) results in specific immune responses. Hence, a broad spectrum second-generation vaccine is highly possible. 

Oncolytic virus

Another strategy includes the oncolytic virus, which kills cancer cells by oncolysis. The direct destruction of malignant cells also requires specific genetic or epigenetic targets present only in such cells. The modern genetic engineering research is now designed using telomerase specific gene with a viral vector. The construct is designed so that only telomerase (hTERT) could express this promoter, which finally leads to selective viral replication and oncolysis of the cell. This strategy has already recorded several milestone achievements, and this could be particularly useful for internal organ tumour treatment where surgery is not easy.

Conclusion

In summary, the study revealed that telomere indeed could be a new and improved target for cancer treatment. However, this field is progressing considerably and is rapidly gaining medical and scientific acceptance. As many technical and conceptual problems are yet to be solved so research still needs to focus on telomerase inhibitors, telomerase vaccines and engineered oncolytic viruses are promising candidates for the treatment of human malignancies.

Post Views: 127
Dr. Namrata Kumari

Dr. Namrata Kumari

Dr. Namrata Kumari is a skilled science communicator with a track record of international high impact publication, extensive experience as director of grant management and editorial board member of scientific journals. She has experience in chemical & biotechnology fields resulting in 7 completed team-based projects.

POPULAR NEWS

  • Why are Men Taller than Women?

    Why are Men Taller than Women?

    0 shares
    Share 0 Tweet 0
  • DENTIST IN SPACE: UPCOMING ERA OF AEROSPACE DENTISTRY

    0 shares
    Share 0 Tweet 0
  • Development and Applications of electronic skin

    0 shares
    Share 0 Tweet 0
  • Discovery of World’s First Animal that Can Survive Without Oxygen

    0 shares
    Share 0 Tweet 0
  • Covid-19: Don’t DIY your immunity

    0 shares
    Share 0 Tweet 0
The Science Serve

We bring you the best Premium WordPress Themes that perfect for news, magazine, personal blog, etc.

Follow us on social media:

Recent News

  • Can memories be transferred?
  • Early life stress and Epigenetics of Depression
  • The first step towards genetic medicine for Transthyretin Amyloidosis

Category

  • Diagnosis
  • Featured
  • Health
  • Healthcare
  • Insights
  • Lifestyle
  • Market
  • Opinion
  • Science
  • Talk
  • Technology
  • Uncategorized

Recent News

Can memories be transferred?

Can memories be transferred?

December 13, 2022
Early life stress and Epigenetics of Depression

Early life stress and Epigenetics of Depression

October 21, 2022

© 2021 Thescienceserve

No Result
View All Result
  • Home
  • Healthcare
  • Technology
  • Market
  • Contact Us
  • More
    • Privacy Policy
    • Disclaimer
    • Editorial Policy and Guidelines
    • Terms and Conditions

© 2021 Thescienceserve

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?